Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Lithuania

European Research Council grant · Running

CoMBi Functional cofactors for targeted modification of biomolecules

Coordinator
Vilniaus Universitetas, Lithuania
Runs
1 April 2025 to 30 September 2026
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101188520

What the project is doing

In the project's own words, from its summary on CORDIS.

Enzymatic addition of a methyl group (methylation) is the most prevalent natural modification in cells, serving a myriad of regulatory and structural functions. Abnormal methylation of DNA, RNA or histone proteins can lead to severe developmental defects and is associated with numerous human diseases. Selective methylation of biomolecular targets is carried out by dedicated methyltransferase enzymes, which use the cofactor S-adenosyl-L-methionine (AdoMet) as the source of methyl groups.

Despite the high specificity and impressive diversity of MTases, the deposited methyl groups are poor reporters and hardly amenable to further derivatization. To unlock the biotechnological power of MTases, strategies for repurposing these enzymes into targeting vehicles for the transfer of useful extended groups from synthetic AdoMet analogs have been devised. However, despite substantial advances over the past decade, a widespread adoption of this enabling technology in scientific labs and clinical settings was grossly hindered by the poor availability of such synthetic cofactors.

This proposal, footed on findings of our ERC-funded work, will seek to overcome the limitations of chemical synthesis and adapt our recently developed chemo-enzymatic protocols for low-cost industrial production of functionally competent AdoMet analogs. We will also seek the transfer of the technology to an industrial partner for its commercial exploitation and to ensure broad access of these valuable reagents to the scientific community and commercial stakeholders.

Topics

Who is involved

OrganisationCityCountryRole
Vilniaus UniversitetasVilniusLithuaniaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI